CA
NZ
UK
AU
IND
US
…
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Sabra Healthcare REIT Inc is a REIT that owns senior housing, skilled nursing and other healthcare properties under long-term leases and mortgage investments. Long-term growth drivers include population aging, sustained demand for post-acute and long-term care and contractual rental cash flows, and the company may appeal to investors seeking healthcare real estate income.
Key risks are tenant and operator credit concentration, sensitivity to Medicare/Medicaid reimbursement and regulatory changes, interest-rate and valuation pressure on REITs, and occupancy or execution risk investors should monitor.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 157.35M | 127.72M | 15.76M | -76.36M | -111.41M |
| Minority interest | 0.10M | 0.00M | 0.00M | - | 0.00M |
| Net income | 155.61M | 126.71M | 13.76M | -77.61M | -113.26M |
| Selling general administrative | 53.71M | 50.07M | 47.47M | 39.57M | 34.67M |
| Gross profit | 503.53M | 476.15M | 452.27M | 462.20M | 428.34M |
| Reconciled depreciation | 187.00M | 169.62M | 183.09M | 187.78M | 178.99M |
| Ebit | 269.84M | 242.99M | 128.72M | 135.57M | 19.04M |
| Ebitda | 456.83M | 412.61M | 311.81M | 323.35M | 198.03M |
| Depreciation and amortization | 187.00M | 169.62M | 183.09M | 187.78M | 178.99M |
| Non operating income net other | - | - | - | -13.52M | -21.95M |
| Operating income | 263.87M | 257.03M | 221.71M | 135.57M | 19.04M |
| Other operating expenses | 510.76M | 446.21M | 425.80M | 390.11M | 358.80M |
| Interest expense | 112.49M | 115.27M | 112.96M | 105.47M | 98.63M |
| Tax provision | 1.84M | 1.00M | 2.00M | 1.24M | 1.84M |
| Net interest income | -112.49M | -115.27M | -112.96M | -105.47M | -98.63M |
| Non recurring | - | - | - | 94.18M | 13.43M |
| Income tax expense | 1.84M | 1.00M | 2.00M | 1.24M | 1.84M |
| Total revenue | 774.63M | 703.24M | 647.51M | 624.81M | 569.54M |
| Total operating expenses | 239.66M | 219.12M | 230.56M | 227.50M | 217.59M |
| Cost of revenue | 271.11M | 227.09M | 195.25M | 162.61M | 141.20M |
| Total other income expense net | -106.52M | -129.31M | -205.95M | -211.94M | -130.45M |
| Net income from continuing ops | 155.51M | 126.71M | 13.76M | 20.43M | 78.83M |
| Net income applicable to common shares | - | - | - | -77.61M | -113.26M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 5493.40M | 5303.68M | 5386.15M | 5747.67M | 5966.71M |
| Intangible assets | 65.32M | 27.46M | 30.90M | 40.13M | 54.06M |
| Other current assets | 6.60M | 5.87M | -46.72M | -406.77M | 3.89M |
| Total liab | 2669.61M | 2562.39M | 2583.62M | 2691.28M | 2587.18M |
| Total stockholder equity | 2821.84M | 2741.29M | 2802.53M | 3056.39M | 3379.53M |
| Other current liab | 119.33M | 117.90M | 34.77M | -196.98M | -1783.28M |
| Common stock | 2.52M | 2.38M | 2.31M | 2.31M | 2.30M |
| Capital stock | 2.52M | 2.38M | 2.31M | 2.31M | 2.30M |
| Retained earnings | -2013.38M | -1874.63M | -1718.28M | -1451.94M | -1095.20M |
| Other liab | - | - | - | 35.13M | 42.44M |
| Other assets | 5245.25M | 387.34M | 5180.16M | 398.93M | 5263.45M |
| Cash | 71.54M | 60.47M | 46.72M | 49.31M | 112.00M |
| Total current liabilities | 336.91M | 224.45M | 231.41M | 142.26M | 142.99M |
| Net debt | 2478.74M | 2384.03M | 2399.92M | 2654.45M | 2282.48M |
| Short term debt | 217.58M | 106.55M | 196.63M | 196.98M | 1783.28M |
| Short long term debt | 217.58M | 106.55M | 94.43M | 196.98M | - |
| Short long term debt total | 2550.28M | 2444.49M | 2446.64M | 2703.76M | 2394.47M |
| Other stockholder equity | 4836.27M | 4592.60M | 4497.07M | 4486.97M | 4482.45M |
| Property plant equipment | - | - | - | 4959.34M | 5162.88M |
| Total current assets | 189.43M | 198.09M | 543.30M | 613.24M | 653.08M |
| Long term investments | 183.52M | 182.92M | 194.69M | 134.96M | 96.68M |
| Net tangible assets | - | - | - | 3016.26M | 3325.47M |
| Short term investments | - | - | - | 411.40M | 399.09M |
| Net receivables | 111.29M | 131.75M | 496.58M | 559.30M | 537.19M |
| Long term debt | 2311.31M | 2311.09M | 2319.67M | 2309.79M | 2394.47M |
| Inventory | - | - | 46.72M | 411.40M | - |
| Accounts payable | - | 67.80M | - | 142.26M | 142.99M |
| Accumulated other comprehensive income | -3.57M | 20.94M | 0.96M | 19.06M | -10.02M |
| Common stock total equity | - | - | - | 2.31M | 2.30M |
| Retained earnings total equity | - | - | - | -1451.94M | -1095.20M |
| Non currrent assets other | 5055.12M | 4895.20M | 4598.34M | 4959.34M | 5162.88M |
| Non current assets total | 5303.96M | 5105.59M | 4842.85M | 5134.44M | 5313.63M |
| Capital lease obligations | 21.38M | 26.85M | 32.53M | - | - |
| Long term debt total | - | - | - | 2309.79M | 2394.47M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | 6.99M | -109.00M | 103.13M | -161.45M | -287.05M |
| Change to liabilities | - | - | - | -13.25M | 14.48M |
| Total cashflows from investing activities | -377.96M | -109.00M | 103.13M | -216.25M | -336.20M |
| Net borrowings | 107.72M | 12.56M | -94.13M | 122.76M | -15.65M |
| Total cash from financing activities | 40.76M | -181.56M | -410.30M | -161.71M | 30.14M |
| Net income | 155.51M | 126.71M | 13.76M | -77.61M | -113.26M |
| Change in cash | 11.80M | 19.62M | -7.21M | -61.95M | 50.36M |
| Begin period cash flow | 66.34M | 46.72M | 53.93M | 115.89M | 65.52M |
| End period cash flow | 78.14M | 66.34M | 46.72M | 53.93M | 115.89M |
| Total cash from operating activities | 348.61M | 310.54M | 300.57M | 315.73M | 356.39M |
| Issuance of capital stock | 227.78M | 86.12M | - | - | - |
| Depreciation | 187.00M | 169.62M | 183.09M | 187.78M | 178.99M |
| Other cashflows from investing activities | -383.70M | -110.86M | 113.93M | 91.88M | 92.95M |
| Dividends paid | 289.50M | 280.15M | 277.45M | -277.16M | -262.92M |
| Change to inventory | - | - | 11.08M | - | - |
| Change to account receivables | -11.45M | -15.46M | -11.08M | -6.44M | 8.22M |
| Sale purchase of stock | - | - | -2.68M | -4.81M | -308.71M |
| Other cashflows from financing activities | -5.24M | -0.09M | -36.04M | 206.34M | 1060.72M |
| Change to netincome | - | - | - | 211.97M | 233.76M |
| Capital expenditures | 0.00M | 0.00M | 5.24M | 146.68M | 33.61M |
| Cash flows other operating | - | - | - | -4.26M | 34.05M |
| Cash and cash equivalents changes | - | - | - | -62.22M | 50.33M |
| Change in working capital | -9.85M | -22.55M | -2.73M | -19.69M | 22.70M |
| Stock based compensation | 11.36M | 8.99M | 7.92M | 7.45M | 7.91M |
| Other non cash items | 4.60M | 27.77M | 98.55M | 217.80M | 32.20M |
| Free cash flow | 348.61M | 310.54M | 300.57M | 315.73M | 322.78M |
Sector: Real Estate Industry: REIT - Healthcare Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| SBRA Sabra Healthcare REIT Inc |
0.18 0.94% |
19.91 | 77.96 | 32.15 | 5.99 | 1.90 | 8.90 | 19.48 |
| WELL Welltower Inc |
2.88 1.21% |
241.88 | 170.68 | 72.46 | 7.75 | 2.13 | 9.77 | 27.67 |
| VTR Ventas Inc |
0.33 0.38% |
87.05 | 161.02 | 131.58 | 7.08 | 3.12 | 9.07 | 24.46 |
| OHI Omega Healthcare Investors Inc |
0.48 1.02% |
47.48 | 16.83 | 10.13 | 11.78 | 2.66 | 14.30 | 12.72 |
| DOC Healthpeak Properties Inc |
0.17 0.90% |
19.66 | 164.70 | 113.64 | 4.06 | 1.58 | 7.64 | 13.08 |
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.
| Name | Title | Year Born |
|---|---|---|
| Mr. Richard K. Matros | Chairman, Pres & CEO | 1954 |
| Mr. Michael Lourenco Costa | Exec. VP, CFO & Sec. | 1979 |
| Ms. Talya Nevo-Hacohen | Exec. VP, Chief Investment Officer & Treasurer | 1960 |
| Mr. Harold W. Andrews Jr. | Consultant | 1964 |
| Mr. Peter W. Nyland | Exec. VP of Asset Management | NA |
| Mr. Darrin L. Smith | Exec. VP of Investments | NA |
| Mr. Lukas Michael Hartwich C.F.A. | Sr. VP of Fin. | NA |
| Ms. Eliza Gozar | Sr. VP of Investments | NA |
| Mr. Richard K. Matros | Chairman, President & CEO | 1954 |
| Mr. Michael Lourenco Costa | Executive VP, CFO & Secretary | 1979 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-0.09%
Communication Services
+0.51%
Consumer Cyclical
-0.11%
Consumer Defensive
-0.44%
Energy
-0.15%
Financial Services
-0.04%
Financials
+0.43%
Healthcare
+0.73%
Industrials
+0.57%
Real Estate
-0.32%
Technology
+1.29%
Utilities
+0.10%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...